Full Succeed holds 6.3% of 20/20 Biolabs

20/20 Biolabs, Inc. joint Schedule 13G discloses that Full Succeed International Limited is the record holder of 651,465 shares of common stock, representing 6.3% of the class based on 10,347,232 shares outstanding as of February 19, 2026.

Rhea-AI Filing Summary

20/20 Biolabs, Inc. joint Schedule 13G discloses that Full Succeed International Limited is the record holder of 651,465 shares of common stock, representing 6.3% of the class based on 10,347,232 shares outstanding as of February 19, 2026. The statement is jointly filed by Full Succeed, and its directors Nengyuan Pan and Wei Lu, who share voting and dispositive power over the shares held by Full Succeed. Each individual disclaims beneficial ownership except for any pecuniary interest. The joint filing is signed and includes a Joint Filing Agreement.

Insights

Corporate Governance Analyst

Joint Schedule 13G reports a passive 6.3% stake held through a BVI entity.

Full Succeed International Limited holds 651,465 shares, with voting and dispositive authority shared by directors Nengyuan Pan and Wei Lu. The filing attributes the shares to the entity while the directors disclaim direct beneficial ownership except to the extent of any pecuniary interest.

The position size is documented relative to 10,347,232 shares outstanding as of February 19, 2026. Future disclosures or amendments would clarify any change in status or intent; timing and cash‑flow treatment are not stated in the excerpt.

FAQ

What stake does Full Succeed hold in 20/20 Biolabs (AIDX)?

Full Succeed holds 651,465 shares, equal to 6.3% of common stock based on 10,347,232 shares outstanding as of February 19, 2026. The shares are held of record by the BVI entity.

Who filed the Schedule 13G for 20/20 Biolabs (AIDX)?

The Schedule 13G was jointly filed by Full Succeed International Limited, and directors Nengyuan Pan and Wei Lu, under a Joint Filing Agreement signed in the filing.

Do Nengyuan Pan and Wei Lu individually own the reported shares?

The filing states the shares are held by Full Succeed; Pan and Lu share voting and dispositive power and each disclaims beneficial ownership except for any pecuniary interest, per the disclosed language.

What is the record date used to calculate the 6.3% ownership?

The percentage is calculated using 10,347,232 shares outstanding as of February 19, 2026, as stated in the cover page comments for each reporting person.

Where is Full Succeed International Limited organized?

Full Succeed International Limited is organized in the British Virgin Islands, as disclosed in the filing's citizenship/place of organization field.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 05:18 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

20/20 Biolabs, Inc.

(Name of Issuer)

Common Stock, par value $0.01

(Title of Class of Securities)

02/19/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

Full Succeed International Limited

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

VIRGIN ISLANDS, BRITISH

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 651,465.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 651,465.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

651,465.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.3 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: The response to Row 11 above is based on 10,347,232 shares of common stock of the Issuer outstanding as of February 19, 2026.

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

Nengyuan Pan

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CHINA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 651,465.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 651,465.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

651,465.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.3 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The number of shares stated above represents shares of common stock held by Full Succeed International Limited. The response to Row 11 above is based on 10,347,232 shares of common stock of the Issuer outstanding as of February 19, 2026.

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

Wei Lu

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CHINA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 651,465.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 651,465.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

651,465.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.3 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The number of shares stated above represents shares of common stock held by Full Succeed International Limited. The response to Row 11 above is based on 10,347,232 shares of common stock of the Issuer outstanding as of February 19, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: 20/20 Biolabs, Inc.
(b)	Address of issuer's principal executive offices: 15810 Gaither Road, Suite 235, Gaithersburg, MD 20877
Item 2.
(a)	Name of person filing: This statement is being jointly filed by Full Succeed International Limited ("Full Succeed"), Nengyuan Pan, an individual, and Wei Lu, an individual (each, a "Reporting Person").
(b)	Address or principal business office or, if none, residence: The principal business address of each Reporting Person is 23F, 1333 Lujiazui Ring Road, Pudong New Area, Shanghai, People's Republic of China
(c)	Citizenship: Full Succeed was organized in the British Virgin Islands. Nengyuan Pan and Wei Lu are citizens of the People's Republic of China.
(d)	Title of class of securities: Common Stock, par value $0.01
(e)	CUSIP No.: 90138K101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Full Succeed is the record holder of 651,465 shares of common stock of the Issuer. Nengyuan Pan and Wei Lu are the Directors of Full Succeed and share voting and dispositive power over the shares held by it. Each of Nengyuan Pan and Wei Lu disclaims beneficial ownership of such shares except to the extent of his or her pecuniary interest, if any, in such shares.
(b)	Percent of class: See Row 11 of the cover page for each Reporting Person.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Rows 5-8 of the cover page for each Reporting Person
	(ii) Shared power to vote or to direct the vote: See Rows 5-8 of the cover page for each Reporting Person
	(iii) Sole power to dispose or to direct the disposition of: See Rows 5-8 of the cover page for each Reporting Person
	(iv) Shared power to dispose or to direct the disposition of: See Rows 5-8 of the cover page for each Reporting Person
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Full Succeed International Limited

Signature:	/s/ Nengyuan Pan
Name/Title:	Nengyuan Pan, Director
Date:	03/10/2026

Nengyuan Pan

Signature:	/s/ Nengyuan Pan
Name/Title:	Nengyuan Pan
Date:	03/10/2026

Wei Lu

Signature:	/s/ Wei Lu
Name/Title:	Wei Lu
Date:	03/10/2026

Exhibit Information

Exhibit 1 - Joint Filing Agreement